CLASS II Device recall · Reported 5 Dec 2018 · FDA Enforcement Report

NxStage PureFlow B Solution-RFP-401, Premixed Dialysate recalled

NxStage Medical is recalling NxStage PureFlow B Solution-RFP-401, Premixed Dialysate for Hemodialysis NxStage PureFlow, distributed nationwide in the US. The recall was initiated on 17 Oct 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot Numbers: F1708229, F1709262, F1709263, F1709264, F1709265, F1709266, F1709273, F1709274, F1709275, F1709278, F1709279, F1709280, F1709281, F1709282, F1709283, F1709284, F1709286, F1709287, Q1709423, Q1709428, Q1709429, F1710296, F1710297, F1710298, F1710315, F1710316, F1710317, F1710318, F1710319, F1710320, F1710324, F1710325, F1710326, Q1710613, Q1710614, Q1710615, F1711330, F1711337, F1711338, Q1711674, Q1711675, Q1711677, Q1711683, Q1711721, Q1711727, Q1711728, Q1711729, Q1711795, Q1711796, Q1711797, Q1711798, Q1711799, Q1711800, Q1711801, Q1711802, Q1711803, Q1712024, Q1712026, Q1712027, Q1712032, Q1712089, Q1712090, Q1712138, Q1712139, Q1712140, Q1712141, Q1712142, Q1801145, Q1801346, Q1801347, Q1802391, Q1802392, Q1802429, Q1802430, Q1802431, Q1802432, Q1802433, Q1802434, Q1802435, Q1802436, Q1802503, Q1802504, Q1802505, Q1802506, Q1802513, Q1803631, Q1803632, Q1803633, Q1803634, Q1803635, Q1803681, Q1803751, Q1803752, Q1803753, Q1803756, Q1803758, Q1803759, Q1803760, Q1803773, Q1803828, Q1803829, Q1803833, Q1803846, Q1804092, Q1804093, Q1804094, Q1804905
Quantity recalled186476

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0501-2019
FDA event ID
81445
Recalling firm
NxStage Medical, Lawrence, MA
Classification
Class II
Status
Terminated
Recall initiated
17 Oct 2018
FDA classified
27 Nov 2018
Reported
5 Dec 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

17 Oct 2018Recall initiated by company
27 Nov 2018Classified by FDA+41 days
5 Dec 2018Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

PureFlow B Solution smaller chamber of the two chamber bag can burst electrolyte fluid and cause injury if it comes in contact with the eyes or skin

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

NxStage PureFlow B Solution-RFP-401, Premixed Dialysate for Hemodialysis NxStage PureFlow B Solution is indicated for use with renal replacement therapy systems that utilize sterile premixed dialysate during hemodialysis.

Where it was distributed

US Nationwide Distribution.

Nationwide

Questions about this recall

Is NxStage PureFlow B Solution-RFP-401, Premixed Dialysate for Hemodialysis NxStage PureFlow recalled?

Yes. NxStage Medical recalled NxStage PureFlow B Solution-RFP-401, Premixed Dialysate for Hemodialysis NxStage PureFlow on 17 Oct 2018. The recall is Class II and its status is Terminated. Recall number Z-0501-2019.

Why was it recalled?

PureFlow B Solution smaller chamber of the two chamber bag can burst electrolyte fluid and cause injury if it comes in contact with the eyes or skin

Which lots are affected?

Lot Numbers: F1708229, F1709262, F1709263, F1709264, F1709265, F1709266, F1709273, F1709274, F1709275, F1709278, F1709279, F1709280, F1709281, F1709282, F1709283, F1709284, F1709286, F1709287, Q1709423, Q1709428, Q1709429, F1710296, F1710297, F1710298, F1710315, F1710316, F1710317, F1710318, F1710319, F1710320, F1710324, F1710325, F1710326, Q1710613, Q1710614, Q1710615, F1711330, F1711337, F1711338, Q1711674, Q1711675, Q1711677, Q1711683, Q1711721, Q1711727, Q1711728, Q1711729, Q1711795, Q1711796, Q1711797, Q1711798, Q1711799, Q1711800, Q1711801, Q1711802, Q1711803, Q1712024, Q1712026, Q1712027, Q1712032, Q1712089, Q1712090, Q1712138, Q1712139, Q1712140, Q1712141, Q1712142, Q1801145, Q1801346, Q1801347, Q1802391, Q1802392, Q1802429, Q1802430, Q1802431, Q1802432, Q1802433, Q1802434, Q1802435, Q1802436, Q1802503, Q1802504, Q1802505, Q1802506, Q1802513, Q1803631, Q1803632, Q1803633, Q1803634, Q1803635, Q1803681, Q1803751, Q1803752, Q1803753, Q1803756, Q1803758, Q1803759, Q1803760, Q1803773, Q1803828, Q1803829, Q1803833, Q1803846, Q1804092, Q1804093, Q1804094, Q1804905

Where was it sold?

US Nationwide Distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from NxStage Medical

All 31

Other Other Medical Devices recalls

All 13,771